Ocular Therapeutix, Inc. (OCUL) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$8.73
+0.29%
Mkt Cap $1.91B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $16.13M | $13.25M | -17.85% | -$0.33 | -$0.29 | +12.12% |
| Q4 2025 Nov 4, 2025 | $16.14M | $14.54M | -9.90% | -$0.39 | -$0.37 | +5.13% |
| Q3 2025 Aug 5, 2025 | $14.57M | $13.46M | -7.60% | -$0.35 | -$0.39 | -11.43% |
| Q2 2025 May 5, 2025 | $13.10M | $10.63M | -18.80% | -$0.29 | -$0.37 | -27.59% |
| Q1 2025 Mar 3, 2025 | $17.11M | $17.08M | -0.17% | -$0.24 | -$0.29 | -20.83% |
| Q4 2024 Nov 14, 2024 | $16.89M | $15.43M | -8.68% | -$0.23 | -$0.26 | -13.04% |
| Q3 2024 Aug 7, 2024 | $15.82M | $16.44M | +3.93% | -$0.22 | -$0.24 | -9.09% |
| Q2 2024 May 7, 2024 | $15.41M | $14.71M | -4.51% | -$0.18 | -$0.24 | -33.33% |
| Q1 2024 Mar 11, 2024 | $15.71M | $14.80M | -5.78% | -$0.28 | -$0.28 | +0.00% |
| Q4 2023 Nov 7, 2023 | $15.87M | $14.95M | -5.80% | -$0.27 | -$0.51 | -88.89% |
| Q3 2023 Aug 7, 2023 | $14.65M | $15.19M | +3.66% | -$0.29 | -$0.27 | +6.90% |
| Q2 2023 May 8, 2023 | $14.10M | $13.37M | -5.15% | -$0.27 | -$0.31 | -14.81% |
| Q1 2023 Mar 6, 2023 | $13.53M | $14.08M | +4.01% | -$0.25 | -$0.24 | +4.00% |
| Q4 2022 Nov 7, 2022 | $14.27M | $11.96M | -16.16% | -$0.23 | -$0.30 | -30.43% |
| Q3 2022 Aug 8, 2022 | $14.25M | $12.27M | -13.91% | -$0.23 | -$0.28 | -21.74% |
| Q2 2022 May 9, 2022 | $13.96M | $13.19M | -5.52% | -$0.25 | -$0.22 | +12.00% |
| Q1 2022 Feb 28, 2022 | $13.94M | $12.31M | -11.71% | -$0.23 | -$0.23 | +0.00% |
| Q4 2021 Nov 8, 2021 | $13.88M | $12.15M | -12.44% | -$0.26 | -$0.23 | +11.54% |
| Q3 2021 Aug 9, 2021 | $11.72M | $11.72M | +0.00% | -$0.20 | -$0.25 | -25.00% |
| Q2 2021 May 5, 2021 | $9.76M | $7.34M | -24.77% | -$0.20 | -$0.24 | -20.00% |
| Q1 2021 Mar 11, 2021 | — | $7.35M | — | -$0.18 | -$0.23 | -27.78% |
| Q4 2020 Nov 5, 2020 | $1.94M | $5.88M | +202.80% | -$0.23 | -$0.17 | +26.09% |
| Q3 2020 Aug 7, 2020 | $1.27M | $1.57M | +23.71% | -$0.32 | -$0.34 | -6.25% |
| Q2 2020 May 8, 2020 | $2.35M | $2.61M | +10.81% | -$0.40 | -$0.41 | -2.50% |
| Q1 2020 Mar 12, 2020 | $1.92M | $2.26M | +17.78% | -$0.42 | -$0.47 | -11.90% |
| Q4 2019 Nov 12, 2019 | $974.08K | $829.00K | -14.89% | -$0.46 | -$0.45 | +2.17% |
| Q3 2019 Aug 7, 2019 | $547.37K | $650.00K | +18.75% | -$0.42 | -$0.57 | -35.71% |
| Q2 2019 May 10, 2019 | $504.00K | $492.00K | -2.38% | -$0.42 | -$0.45 | -7.14% |
| Q1 2019 Mar 7, 2019 | $456.00K | $504.00K | +10.53% | -$0.37 | -$0.42 | -13.51% |
| Q4 2018 Nov 7, 2018 | $498.00K | $498.00K | +0.00% | -$0.36 | -$0.38 | -5.56% |
| Q3 2018 Aug 7, 2018 | $648.00K | $648.00K | +0.00% | -$0.37 | -$0.37 | +0.00% |
| Q2 2018 May 8, 2018 | $323.00K | $340.00K | +5.26% | -$0.39 | -$0.40 | -2.56% |
| Q1 2018 Mar 8, 2018 | $575.54K | $487.00K | -15.38% | -$0.58 | -$0.44 | +24.14% |
| Q4 2017 Nov 7, 2017 | $513.31K | $523.00K | +1.89% | -$0.54 | -$0.54 | +0.00% |
| Q3 2017 Aug 8, 2017 | $383.25K | $438.00K | +14.29% | -$0.59 | -$0.64 | -8.47% |
| Q2 2017 May 5, 2017 | $393.10K | $475.00K | +20.83% | -$0.48 | -$0.58 | -20.83% |
| Q1 2017 Mar 10, 2017 | $442.21K | $511.00K | +15.56% | -$0.47 | -$0.45 | +4.26% |
| Q4 2016 Nov 9, 2016 | $611.54K | $477.00K | -22.00% | -$0.51 | -$0.33 | +35.29% |
| Q3 2016 Aug 9, 2016 | $469.76K | $441.00K | -6.12% | -$0.49 | -$0.40 | +18.37% |
| Q2 2016 May 10, 2016 | $447.59K | $458.00K | +2.33% | -$0.45 | -$0.39 | +13.33% |
| Q1 2016 Mar 10, 2016 | $476.56K | $436.00K | -8.51% | -$0.46 | -$0.38 | +17.39% |
| Q4 2015 Nov 10, 2015 | $346.85K | $429.00K | +23.68% | -$0.33 | -$0.42 | -27.27% |
| Q3 2015 Aug 10, 2015 | $336.60K | $459.00K | +36.36% | -$0.33 | -$0.40 | -21.21% |
| Q2 2015 May 15, 2015 | $474.69K | $426.00K | -10.26% | -$0.39 | -$0.31 | +20.51% |
| Q1 2015 Mar 10, 2015 | $518.65K | $505.00K | -2.63% | -$0.40 | -$0.32 | +20.00% |
| Q4 2014 Nov 12, 2014 | $128.10K | $97.00K | -24.28% | -$0.55 | -$0.44 | +20.00% |
| Q1 2014 Mar 31, 2014 | — | $27.00K | — | — | -$2.45 | — |
| Q4 2013 Dec 31, 2013 | — | — | — | — | -$1.34 | — |
| Q3 2013 Sep 30, 2013 | — | — | — | — | -$1.34 | — |
| Q2 2013 Jun 30, 2013 | — | — | — | — | -$1.19 | — |
| Q1 2013 Mar 31, 2013 | — | — | — | — | -$0.21 | — |